The impact of medication therapy management in older oncology patients
- 854 Downloads
This project aimed to identify common drug-related problems (DRP) among elderly cancer patients, to determine the effectiveness of medication therapy management (MTM) service in resolving DRP, to determine the clinical significance of pharmacist interventions, and to determine patients’ satisfaction level of MTM service.
Elderly cancer patients (age ≥65) who were at least on one chronic medication would be eligible for the MTM service. Any DRP that was detected would be recorded and steps to resolve it were taken. Pre- and post-service patient satisfaction surveys (PSS) were conducted before and after MTM. All interventions performed by MTM pharmacists were subjected to independent evaluation by a panel of three judges.
One hundred eighteen patients received at least one session of MTM. We identified and attempted to resolve 361 DRPs, and the most common DRPs were drug interactions (117 cases, 32.4 %), adverse effects (114 cases, 31.6 %), and non-adherence (48 cases, 13.3 %). Forty-four interventions were performed by pharmacists and forty cases (91 %) were accepted by physicians. Almost two third of these interventions were deemed significant (or higher) by the judges. Seventy-two patients completed PSS. There was statistically significant improvement in patients’ satisfaction level after the service was provided.
MTM is an important platform in identifying and managing DRPs. Patients are generally satisfied with MTM services.
KeywordsMedication therapy management Drug-related problems Elderly cancer patients
Conflict of interest
The authors of this manuscript have full control of all primary data and we are agreeable to allowing the journal to review our data if requested.
This study was done with funding from the Healthcare Quality Improvement Funding, Ministry of Health, Singapore.
- 1.American Pharmacist Association (APhA). (2004) Medication therapy management services definition and program criteria Jul 2004. Available at http://www.aacp.org/resources/historicaldocuments/Documents/MTMServicesDefinitionandProgramCriteria04.pdf. Assessed 05 October 2011
- 2.American College of Clinical Pharmacy Position Statement (2004) Medication therapy management services definition and program criteria. Available at http://www.accp.com/docs/positions/positionStatements/pos032_200407.pdf. Assessed 24 October 2011
- 3.Oliveira DR, Brummel AR, Miller DB (2007) Medication therapy management: 10 years of experience in a large integrated health care system. J Manag Care Pharm 16(3):185–195Google Scholar
- 5.http://www.un.org/esa/population/publications/worldageing19502050. Assessed 19 September 2011
- 7.Population Reference Bureau (2010) Today’s research on aging. July. No. 20. http://www.prb.org/pdf10/TodaysResearchAging20.pdf. Assessed 16 September 2011
- 8.http://www.mcys.gov.sg/successful_ageing/Report.html. Accessed 22 November 2009
- 10.Terret C (2005) Geriatric oncology—a challenge for the future. Eur Oncol Rev 24–26Google Scholar
- 12.http://www.moh.gov.sg/mohcorp/statistics.aspx?id=5526. Assessed 22 November 2009
- 14.Poon D (2008) Challenges in the practice of geriatric oncology in a national comprehensive cancer centre in Asia. Asia-Pac Oncol Haematol 1:67–68Google Scholar
- 15.American Society of Hospital Pharmacists (1993) ASHP statement on pharmaceutical care. Am J Hosp Pharm 50:1720–1723Google Scholar
- 24.Extermann M, Boler I, Reich R et al (2010) The Chemotherapy Risk Assessment Scale for High-age patients (CRASH) score: design and validation. J Clin Oncol 28:15s, suppl; abstract 9000Google Scholar
- 31.Chumney EC, Robinson LC (2006) The effects of pharmacist interventions on patients with polypharmacy. Pharm Pract 4(3):103–109Google Scholar
- 34.Alsoud NA, El-Hamamsy M, Zawahry HA, Al-Azizi M (2010) Effects of clinical pharmacist interventions on clinical outcomes in oncology patients. Res J Med Med Sci 5(2):133–141Google Scholar
- 35.Ganachari MS, Mahendra Kumar BJ, Shashikala CW, Fibin M (2010) Assessment of drug therapy interventions by clinical pharmacist in a tertiary care hospital. Indian J Pharm Pract 3(3):22–28Google Scholar